California Public Employees Retirement System Reata Pharmaceuticals Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$24.12 - $39.6 $1.31 Million - $2.15 Million	-54,226 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$25.61 - $110.96 $57,084 - $247,329	-2,229 Reduced 3.95%	54,226 $1.43 Million
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $2.7 Million - $5.21 Million	-34,468 Reduced 37.91%	56,455 $7.99 Million
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $3.72 Million - $5.24 Million	39,492 Added 76.79%	90,923 $9.07 Million
Q4 2020 Feb 02, 2021	BUY	$102.03 - $184.62 $96,622 - $174,835	947 Added 1.88%	51,431 $6.36 Million
Q3 2020 Nov 05, 2020	SELL	$93.53 - $163.34 $242,897 - $424,193	-2,597 Reduced 4.89%	50,484 $4.92 Million
Q2 2020 Aug 12, 2020	BUY	$126.3 - $176.56 $316,255 - $442,106	2,504 Added 4.95%	53,081 $8.28 Million
Q1 2020 May 12, 2020	SELL	$124.16 - $247.74 $2.48 Million - $4.95 Million	-19,970 Reduced 28.31%	50,577 $7.3 Million
Q4 2019 Jan 27, 2020	BUY	$74.57 - $217.92 $2.49 Million - $7.28 Million	33,428 Added 90.06%	70,547 $14.4 Million
Q3 2019 Oct 31, 2019	BUY	$71.26 - $95.75 $312,403 - $419,768	4,384 Added 13.39%	37,119 $2.98 Million
Q2 2019 Aug 15, 2019	SELL	$77.72 - $94.35 $20,673 - $25,097	-266 Reduced 0.81%	32,735 $3.09 Million
Q1 2019 May 03, 2019	BUY	$51.9 - $101.79 $233,446 - $457,851	4,498 Added 15.78%	33,001 $2.82 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $76.44 $1.22 Million - $1.91 Million	25,000 Added 713.67%	28,503 $1.6 Million
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $124,846 - $322,486	3,503 New	3,503 $286,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account